Khang Wen Pang1, Chun Han Nigel Tan1, Stanley Loh2, Kin Yong Stephen Chang1, Shridhar Ganpathi Iyer1, Krishnakumar Madhavan1, Wei Chieh Alfred Kow3. 1. Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, National University Health System Singapore, National University of Singapore, 1E Kent Ridge Road, NUHS Tower Block, Level 8, Singapore, Singapore. 2. Department of Diagnostic Imaging, National University Hospital, Singapore, Singapore. 3. Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, National University Health System Singapore, National University of Singapore, 1E Kent Ridge Road, NUHS Tower Block, Level 8, Singapore, Singapore. alfred_kow@nuhs.edu.sg.
Abstract
BACKGROUND: Acute cholecystitis (AC) is an important cause of emergency admissions among the elderly. The use of percutaneous cholecystostomy (PC) as bridging therapy among high-risk patients is widely accepted. However, the use of PC as definitive treatment is controversial. AIM: To determine the characteristics, clinical outcomes and predictors of recurrence of AC among patients who underwent PC. METHODS: A retrospective case series of 71 consecutive patients [73 (38-96) years, 43/71 males] treated with PC for AC at a tertiary hospital from 2007 to 2013, with data collected from case records. RESULTS: Patients were followed up for 37.0 (0.1-110.8) months after PC. Mortality rate was 8.5 % (6/71) during the index admission and 32.4 % (23/71) at the end of follow-up. Recurrence rate for AC was 11.9 % (7/59). Median time to recurrence was 62 (13-464) days. PC was definitive treatment in 33/59. Predictors of recurrence were higher serum alkaline phosphatase (ALP) at diagnosis (OR = 1.01, 95 % CI 1.00-1.02, p = 0.021) and acute myocardial infarction (AMI) during index admission (OR = 8.00, 95 % CI 1.19-54.0, p = 0.033). Fifteen patients (26.3 %, 15/71) had post-procedural complications including dislodgement (14 %, 10/71), tube obstruction (7.0 %, 5/71), bile leaks (2.8 %, 2/71), gallbladder perforation (1.4 %, 1/71), bowels perforation (1.4 %, 1/71) and severe post-procedural haemorrhage (1.4 %, 1/71). CONCLUSION: PC is effective and relatively safe in high-risk patients with AC. However, patients with higher ALP or AMI during index admission have higher risk of recurrence and might benefit from definitive cholecystectomy.
BACKGROUND: Acute cholecystitis (AC) is an important cause of emergency admissions among the elderly. The use of percutaneous cholecystostomy (PC) as bridging therapy among high-risk patients is widely accepted. However, the use of PC as definitive treatment is controversial. AIM: To determine the characteristics, clinical outcomes and predictors of recurrence of AC among patients who underwent PC. METHODS: A retrospective case series of 71 consecutive patients [73 (38-96) years, 43/71 males] treated with PC for AC at a tertiary hospital from 2007 to 2013, with data collected from case records. RESULTS:Patients were followed up for 37.0 (0.1-110.8) months after PC. Mortality rate was 8.5 % (6/71) during the index admission and 32.4 % (23/71) at the end of follow-up. Recurrence rate for AC was 11.9 % (7/59). Median time to recurrence was 62 (13-464) days. PC was definitive treatment in 33/59. Predictors of recurrence were higher serum alkaline phosphatase (ALP) at diagnosis (OR = 1.01, 95 % CI 1.00-1.02, p = 0.021) and acute myocardial infarction (AMI) during index admission (OR = 8.00, 95 % CI 1.19-54.0, p = 0.033). Fifteen patients (26.3 %, 15/71) had post-procedural complications including dislodgement (14 %, 10/71), tube obstruction (7.0 %, 5/71), bile leaks (2.8 %, 2/71), gallbladder perforation (1.4 %, 1/71), bowels perforation (1.4 %, 1/71) and severe post-procedural haemorrhage (1.4 %, 1/71). CONCLUSION:PC is effective and relatively safe in high-risk patients with AC. However, patients with higher ALP or AMI during index admission have higher risk of recurrence and might benefit from definitive cholecystectomy.
Authors: Torben Horn; Sara D Christensen; Jakob Kirkegård; Lars P Larsen; Anders R Knudsen; Frank V Mortensen Journal: HPB (Oxford) Date: 2014-11-14 Impact factor: 3.647
Authors: Kohji Okamoto; Tadahiro Takada; Steven M Strasberg; Joseph S Solomkin; Henry A Pitt; O James Garden; Markus W Büchler; Masahiro Yoshida; Fumihiko Miura; Yasutoshi Kimura; Ryota Higuchi; Yuichi Yamashita; Toshihiko Mayumi; Harumi Gomi; Shinya Kusachi; Seiki Kiriyama; Masamichi Yokoe; Wan-Yee Lau; Myung-Hwan Kim Journal: J Hepatobiliary Pancreat Sci Date: 2013-01 Impact factor: 7.027
Authors: Byung Hyo Cha; Ha Hun Song; Young Nam Kim; Won Jung Jeon; Sang Jin Lee; Jin Dong Kim; Hak Hyun Lee; Ban Seok Lee; Sang Hyub Lee Journal: Korean J Gastroenterol Date: 2014-01-25
Authors: M W Little; J H Briggs; C R Tapping; M J Bratby; S Anthony; J Phillips-Hughes; R Uberoi Journal: Clin Radiol Date: 2013-03-21 Impact factor: 2.350
Authors: Masahiko Hirota; Tadahiro Takada; Yoshifumi Kawarada; Yuji Nimura; Fumihiko Miura; Koichi Hirata; Toshihiko Mayumi; Masahiro Yoshida; Steven Strasberg; Henry Pitt; Thomas R Gadacz; Eduardo de Santibanes; Dirk J Gouma; Joseph S Solomkin; Jacques Belghiti; Horst Neuhaus; Markus W Büchler; Sheung-Tat Fan; Chen-Guo Ker; Robert T Padbury; Kui-Hin Liau; Serafin C Hilvano; Giulio Belli; John A Windsor; Christos Dervenis Journal: J Hepatobiliary Pancreat Surg Date: 2007-01-30
Authors: Ye Rim Chang; Young-Joon Ahn; Jin-Young Jang; Mee Joo Kang; Wooil Kwon; Woo Hyun Jung; Sun-Whe Kim Journal: Surgery Date: 2014-01-11 Impact factor: 3.982
Authors: Kirsten Kortram; Bert van Ramshorst; Thomas L Bollen; Marc G H Besselink; Dirk J Gouma; Tom Karsten; Philip M Kruyt; Grard A P Nieuwenhuijzen; Johannes C Kelder; Ellen Tromp; Djamila Boerma Journal: Trials Date: 2012-01-12 Impact factor: 2.279